Elevation Oncology ELEV 深 沪
已收盘 07-23 16:00:00 美东时间
0.365
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.365
- 总市值 2161.67万
- 52周最高 2.2599
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.221
- 委 比 0.00%
- 总股本 5922.37万
- 历史最高 16.22
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.221
- 每 手 1
- 风险率 0.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SA analyst upgrades/downgrades: XPENG, GOOG, MNSO, SRPT
The Asian Investor sees significant improvement in XPeng’s (XPEV) vehicle margin profile, leading to a more positive outlook on the stock. In contrast, Seeking Alpha analysts have made notable downgra...
08-23 01:55
J.B. Hunt appoints Brad Delco as CFO
J.B. Hunt Transport Services (NASDAQ:JBHT) on Thursday said that it has appointed Brad Delco as the new CFO and Executive Vice President of Finance, effective September 1, 2025. Delco joined the compa...
08-22 04:34
Sarepta Therapeutics refinances $700M of convertible notes
Sarepta Therapeutics (NASDAQ:SRPT) reached agreements with select noteholders to exchange about $700M of its 1.25% convertible notes due 2027 for $602M of new 4.875% notes due 2030, up to 6.7M shares ...
08-21 19:15
行业观察：裁员浪潮为什么还在席卷生物医药？
（来源：药研网） 导语 News Today 今年的裁员潮在生物医药行业持续升温，早已超出过去所谓的“2024年高峰”。 今年上半年，已有 130 家生物科技与...
08-20 12:06
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sarepta To Contact Him Directly To Discuss Their Options If you purchased o...
08-15 00:14
跨国药企洞察｜默沙东终止康方2亿美元合作项目，跨国药企如何“优中选优”？
（来源：动脉新医药） 编者按： 全球视野下的跨国药企深度洞察——创新、博弈与中国答卷 在全球医药产业发展的宏大叙事中，跨国药企始终扮演着关键角色——他们...
08-12 08:02
FDA vaccines head, chief medical officer Vinay Prasad departs agency
Vinay Prasad, who headed the U.S. FDA division in charge of vaccines and was also chief medical and scientific officer, has abruptly left the agency. He joined the FDA in May as director of the Center...
07-30 15:00
Sarepta Therapeutics shares are trading higher after the company announced ELEVIDYS was not linked to a recent patient death in Brazil.
Sarepta Therapeutics shares are trading higher after the company announced ELEV...
07-28 22:39
Arrowhead expects Sarepta to honor financial obligations
Arrowhead Pharmaceuticals (NASDAQ:ARWR) announced Wednesday that it expects its partner Sarepta Therapeutics (NASDAQ:SRPT), which recently withdrew its gene therapy Elevidys from the U.S. market, will...
07-23 22:25
Elevation Oncology Completes Merger with Concentra Biosciences
Elevation Oncology ( ($ELEV) ) has issued an update. Elevation Oncology, Inc. a...
07-23 21:48
